Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

12 questions · 12 findings · 2 reviews

No studies found 9 · 75%GRADE not reported 0 · 0%Very low 3 · 25%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

UVA1 vs narrowband UVB

Proportion of participants with adverse effects serious or severe enough to have caused withdrawal ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs narrowband UVB

Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs narrowband UVB

Proportion of participants achieving a 50% reduction in disease severity ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs narrowband UVB

Proportion of participants without relapse in the long term ‐ not reported · chronic palmoplantar pustulosis

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs PUVA

Physician‐assessed changes in clinical signs · atopic eczema
1 finding from 1 review

UVA1 vs PUVA

Patient‐reported changes in symptoms ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs PUVA

Investigator Global Assessment ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs PUVA

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

UVA1 vs PUVA

Withdrawals due to adverse events not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review